Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

Author(s):
Zunder, S.M.; Pelt, G.W. van (0000-0003-1449-7348); Gelderblom, H.J.; Mancao, C.; Putter, H.; Tollenaar, R.A.; Mesker, W.E. (0000-0001-5533-4778)
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-17
Language
English
Is part of
British Journal of Cancer (2018), Vol. 119, no. 2, p. 164-169
hdl
1887/79229
doi
10.1038/s41416-018-0083-0